Why the study?
Does concomitant use of proton pump inhibitors reduce the efficacy of clopidogrel and increase cardiovascular events in patients on dual antiplatelet therapy?
Population
Patients prescribed clopidogrel plus aspirin
Comparison
Proton pump inhibitors (specifically omeprazole) vs Placebo or no proton pump inhibitor
Design
Review
Authors
Loading...
No support for avoiding PPIs with clopidogrel; leaves open reconciliation with conflicting observational data.
Does concomitant use of proton pump inhibitors reduce the efficacy of clopidogrel and increase cardiovascular events in patients on dual antiplatelet therapy?
Despite observational data and FDA warnings, randomized trial evidence does not support a causal link between PPI use and increased cardiovascular events in patients taking clopidogrel.
Laine et al. (2009) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: